PlainRecalls
FDA Drug Low Class III Terminated

Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.

Reported: October 9, 2013 Initiated: September 16, 2013 #D-1067-2013

Product Description

Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.

Reason for Recall

Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.

Details

Units Affected
57857 bottles
Distribution
Nationwide
Location
Marietta, GA

Frequently Asked Questions

What product was recalled?
Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.. Recalled by Osmotica Pharmaceutical Corp. Units affected: 57857 bottles.
Why was this product recalled?
Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 9, 2013. Severity: Low. Recall number: D-1067-2013.